CAR-T Cell Therapy Market: By Targeted Antigen (CD 19, CD 20, GD2, CD22, CD30, CD33, HER1, HER2, Meso, EGFRvlll), By Therapeutic Application (Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin Leukemia, Multiple Myeloma, Pancreatic Cancer, Neuroblasta, Breast Cancer, Acute Myeloid Leukemia, Hepatocellular Carcinoma, Colorectal Cancer), and Geography   

Purchase Option

$ 4400
$ 6600
$ 8900

CAR-T Cell Therapy Market size was valued at USD 2.1 billion in 2023 and is poised to grow at a CAGR of 14.2% from 2024 to 2030. The global market provides a detailed overview of the market and that can be segmented by targeted antigen and therapeutic application. By targeted antigen, the CAR-T cell therapy market has been segmented into CD 19, CD 20, GD2, CD22, CD30, CD33, HER1, HER2, Meso, and EGFRvlll. The CD 19 segment is likely to be the largest and fastest-growing segment in terms of targeted antigen. Based on therapeutic application, the CAR-T cell therapy market is segmented into leukemia, chronic lymphocytic leukemia, non-Hodgkin leukemia, multiple myeloma, pancreatic cancer, neuroblasts, breast cancer, and acute myeloid leukemia, hepatocellular carcinoma, and colorectal cancer. Among these, the non-Hodgkin leukemia segment is expected to have the fastest-growing market during the forecast period.

Global Car T Cell Therapy Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

14.2%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
CAR-T Cell Therapy Market Dynamics

CAR-T cell therapy solutions are receiving more approvals, the prevalence of obesity together with rising cancer case, growing demand for effective treatments for cancer, and huge steady investment activities by pharmaceutical companies' are some key factors fostering the market growth.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Car T Cell Therapy Market Segmentation

By Targeted Antigen
  • CD 19
  • CD 20
  • GD2
  • CD22
  • CD30
  • CD33
  • HER1
  • HER2
  • Meso
  • EGFRvlll
By Therapeutic Application
  • Leukemia
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Leukemia
  • Multiple Myeloma
  • Pancreatic Cancer
  • Neuroblasta
  • Breast Cancer
  • Acute Myeloid Leukemia
  • Hepatocellular Carcinoma
  • Colorectal Cancer
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

The CAR-T cell therapy market size was valued at USD 2.1 billion in 2023

Biopolymer GmbH & Co KG (Germany), Merz GmbH & Co. KGaA (Germany), Lumenis (U.S.), Revance Therapeutics, Inc. (U.S), Speciality European Pharma (U.K.), Mentor Worldwide LLC (U.K.), Anika Therapeutics, Inc. (U.S.), Contura International A/S (Denmark), Cynosure, Inc. (U.S.), Fibrocell Science Inc. (U.S), Galderma S/A (Switzerland)

Asia-Pacific is the fastest-growing region for CAR-T cell therapy market

1.Executive Summary
2.Global CAR-T Cell Therapy Market Introduction 
2.1.Global CAR-T Cell Therapy Market  - Taxonomy
2.2.Global CAR-T Cell Therapy Market  - Definitions
2.2.1. By Targeted Antigen
2.2.2. By Therapeutic Application
2.2.3. By Region
3.Global CAR-T Cell Therapy Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global CAR-T Cell Therapy Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global CAR-T Cell Therapy Market  By Targeted Antigen, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. CD 19
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. CD 20
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. GD2
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. CD22
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. CD30
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. CD33
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. HER1
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. HER2
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
5.9. Meso
5.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.9.3. Market Opportunity Analysis 
5.10. EGFRvlll
5.10.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.10.3. Market Opportunity Analysis 
6.Global CAR-T Cell Therapy Market  By Therapeutic Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Leukemia
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Chronic Lymphocytic Leukemia
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Non Hodgkin Leukemia
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Multiple Myeloma
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Pancreatic Cancer
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Neuroblasta
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Breast Cancer
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. Acute Myeloid Leukemia
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
6.9. Hepatocellular Carcinoma
6.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.9.3. Market Opportunity Analysis 
6.10. Colorectal Cancer
6.10.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.10.3. Market Opportunity Analysis 
7.Global CAR-T Cell Therapy Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America CAR-T Cell Therapy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Targeted Antigen Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.CD 19
8.1.2.CD 20
8.1.3.GD2
8.1.4.CD22
8.1.5.CD30
8.1.6.CD33
8.1.7.HER1
8.1.8.HER2
8.1.9.Meso
8.1.10.EGFRvlll
8.2.  Therapeutic Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Leukemia
8.2.2.Chronic Lymphocytic Leukemia
8.2.3.Non Hodgkin Leukemia
8.2.4.Multiple Myeloma
8.2.5.Pancreatic Cancer
8.2.6.Neuroblasta
8.2.7.Breast Cancer
8.2.8.Acute Myeloid Leukemia
8.2.9.Hepatocellular Carcinoma
8.2.10.Colorectal Cancer
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe CAR-T Cell Therapy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Targeted Antigen Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.CD 19
9.1.2.CD 20
9.1.3.GD2
9.1.4.CD22
9.1.5.CD30
9.1.6.CD33
9.1.7.HER1
9.1.8.HER2
9.1.9.Meso
9.1.10.EGFRvlll
9.2.  Therapeutic Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Leukemia
9.2.2.Chronic Lymphocytic Leukemia
9.2.3.Non Hodgkin Leukemia
9.2.4.Multiple Myeloma
9.2.5.Pancreatic Cancer
9.2.6.Neuroblasta
9.2.7.Breast Cancer
9.2.8.Acute Myeloid Leukemia
9.2.9.Hepatocellular Carcinoma
9.2.10.Colorectal Cancer
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) CAR-T Cell Therapy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Targeted Antigen Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.CD 19
10.1.2.CD 20
10.1.3.GD2
10.1.4.CD22
10.1.5.CD30
10.1.6.CD33
10.1.7.HER1
10.1.8.HER2
10.1.9.Meso
10.1.10.EGFRvlll
10.2.  Therapeutic Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Leukemia
10.2.2.Chronic Lymphocytic Leukemia
10.2.3.Non Hodgkin Leukemia
10.2.4.Multiple Myeloma
10.2.5.Pancreatic Cancer
10.2.6.Neuroblasta
10.2.7.Breast Cancer
10.2.8.Acute Myeloid Leukemia
10.2.9.Hepatocellular Carcinoma
10.2.10.Colorectal Cancer
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) CAR-T Cell Therapy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Targeted Antigen Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.CD 19
11.1.2.CD 20
11.1.3.GD2
11.1.4.CD22
11.1.5.CD30
11.1.6.CD33
11.1.7.HER1
11.1.8.HER2
11.1.9.Meso
11.1.10.EGFRvlll
11.2.  Therapeutic Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Leukemia
11.2.2.Chronic Lymphocytic Leukemia
11.2.3.Non Hodgkin Leukemia
11.2.4.Multiple Myeloma
11.2.5.Pancreatic Cancer
11.2.6.Neuroblasta
11.2.7.Breast Cancer
11.2.8.Acute Myeloid Leukemia
11.2.9.Hepatocellular Carcinoma
11.2.10.Colorectal Cancer
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America CAR-T Cell Therapy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Targeted Antigen Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.CD 19
12.1.2.CD 20
12.1.3.GD2
12.1.4.CD22
12.1.5.CD30
12.1.6.CD33
12.1.7.HER1
12.1.8.HER2
12.1.9.Meso
12.1.10.EGFRvlll
12.2.  Therapeutic Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Leukemia
12.2.2.Chronic Lymphocytic Leukemia
12.2.3.Non Hodgkin Leukemia
12.2.4.Multiple Myeloma
12.2.5.Pancreatic Cancer
12.2.6.Neuroblasta
12.2.7.Breast Cancer
12.2.8.Acute Myeloid Leukemia
12.2.9.Hepatocellular Carcinoma
12.2.10.Colorectal Cancer
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Biopolymer GmbH & Co KG (Germany)
13.2.2.Merz GmbH & Co. KGaA (Germany)
13.2.3.Lumenis (U.S.)
13.2.4.Revance Therapeutics, Inc. (U.S)
13.2.5.Speciality European Pharma (U.K.)
13.2.6.Mentor Worldwide LLC (U.K.)
13.2.7.Anika Therapeutics, Inc. (U.S.)
13.2.8.Contura International A/S (Denmark)
13.2.9.Cynosure, Inc. (U.S.)
13.2.10.Fibrocell Science Inc. (U.S)
13.2.11.Galderma S/A (Switzerland)
14. Research Methodology 
15. Appendix and Abbreviations 
  • Biopolymer GmbH & Co KG (Germany)
  • Merz GmbH & Co. KGaA (Germany)
  • Lumenis (U.S.)
  • Revance Therapeutics, Inc. (U.S)
  • Speciality European Pharma (U.K.)
  • Mentor Worldwide LLC (U.K.)
  • Anika Therapeutics, Inc. (U.S.)
  • Contura International A/S (Denmark)
  • Cynosure, Inc. (U.S.)
  • Fibrocell Science Inc. (U.S)
  • Galderma S/A (Switzerland)

Adjacent Markets